Nothing Special   »   [go: up one dir, main page]

WO2010091169A3 - Preparation of valsartan - Google Patents

Preparation of valsartan Download PDF

Info

Publication number
WO2010091169A3
WO2010091169A3 PCT/US2010/023180 US2010023180W WO2010091169A3 WO 2010091169 A3 WO2010091169 A3 WO 2010091169A3 US 2010023180 W US2010023180 W US 2010023180W WO 2010091169 A3 WO2010091169 A3 WO 2010091169A3
Authority
WO
WIPO (PCT)
Prior art keywords
valsartan
preparation
processes
preparing
essentially amorphous
Prior art date
Application number
PCT/US2010/023180
Other languages
French (fr)
Other versions
WO2010091169A2 (en
Inventor
Raghupathi Reddy Anumula
Goverdhan Gilla
Sampath Aalla
Yakambram Bojja
Thirupathi Akkireddy
Rahul Gawale
Venkata Rama Krishna Medisetti
Kushal Surajmal Manudhane
Santosh Reddy Narra
Srinivas Yadav Enugula
Srinivasa Reddy Bhimavarapu
Original Assignee
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc. filed Critical Dr. Reddy's Laboratories Ltd.
Publication of WO2010091169A2 publication Critical patent/WO2010091169A2/en
Publication of WO2010091169A3 publication Critical patent/WO2010091169A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Processes for preparing valsartan and essentially amorphous valsartan are described.
PCT/US2010/023180 2009-02-04 2010-02-04 Preparation of valsartan WO2010091169A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN247CH2009 2009-02-04
IN247/CHE/2009 2009-02-04
US18501909P 2009-06-08 2009-06-08
US61/185,019 2009-06-08

Publications (2)

Publication Number Publication Date
WO2010091169A2 WO2010091169A2 (en) 2010-08-12
WO2010091169A3 true WO2010091169A3 (en) 2010-12-29

Family

ID=42542646

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/023180 WO2010091169A2 (en) 2009-02-04 2010-02-04 Preparation of valsartan

Country Status (1)

Country Link
WO (1) WO2010091169A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015056219A1 (en) * 2013-10-18 2015-04-23 Ranbaxy Laboratories Limited Process for simultaneous drying and micronization of valsartan
US10562866B2 (en) * 2015-02-06 2020-02-18 Mylan Laboratories Limited Amorphous trisodium sacubitril valsartan and a process for the preparation thereof
WO2019135691A1 (en) * 2018-01-04 2019-07-11 Jamjoom Pharmaceuticals Factory Company Limited A stable mono-layer solid dosage form containing combination of two active ingredients
EP3939967A1 (en) 2020-07-15 2022-01-19 KRKA, d.d., Novo mesto A continuous process for the preparation of (s)-methyl n-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-n-pentanoylvalinate in a flow reactor

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087681A1 (en) * 2003-03-31 2004-10-14 Hetero Drugs Limited A novel amorphous form of valsartan
US20060149079A1 (en) * 2005-01-03 2006-07-06 Padi Pratap R Process for preparing valsartan
WO2006076561A1 (en) * 2005-01-11 2006-07-20 Teva Pharmaceutical Industries Ltd. Process for preparing amorphous valsartan
US7361770B2 (en) * 2003-06-16 2008-04-22 Hetero Drugs Limited Process for preparation of valsartan
US20080261959A1 (en) * 2005-05-25 2008-10-23 Ashok Kumar Novel crystalline forms of (S)-N-(1-Carboxy-2-methyl-prop-1-y)-N-pentanoyl-N[2'-(1H-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087681A1 (en) * 2003-03-31 2004-10-14 Hetero Drugs Limited A novel amorphous form of valsartan
US7361770B2 (en) * 2003-06-16 2008-04-22 Hetero Drugs Limited Process for preparation of valsartan
US20060149079A1 (en) * 2005-01-03 2006-07-06 Padi Pratap R Process for preparing valsartan
WO2006076561A1 (en) * 2005-01-11 2006-07-20 Teva Pharmaceutical Industries Ltd. Process for preparing amorphous valsartan
US20080261959A1 (en) * 2005-05-25 2008-10-23 Ashok Kumar Novel crystalline forms of (S)-N-(1-Carboxy-2-methyl-prop-1-y)-N-pentanoyl-N[2'-(1H-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine

Also Published As

Publication number Publication date
WO2010091169A2 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
EP2467173B8 (en) Wound dressings, methods of using the same and methods of forming the same
EP2977028B8 (en) Prosthesis
EP2519599A4 (en) Method of selecting refrigerant-lubricant combinations
PL2477992T3 (en) Processes for the preparation of darunavir and the amorphous form thereof
EP3342292B8 (en) Solid milk and method for manufacture thereof
EP2633993A4 (en) Stretchable sheet manufacturing method
WO2011139886A3 (en) Preparation of febuxostat
WO2010091169A3 (en) Preparation of valsartan
EP2367836B8 (en) Process for the preparation and purification of topiramate
WO2010148209A3 (en) Preparation of montelukast
PT2655363T (en) Crystalline forms and processes for their preparation
EP2650082A4 (en) Ceramic composite for photoconversion, and method for manufacture thereof
AU2015210341B2 (en) Buckle
AU2009904566A0 (en) Method of manufacture
AU2009905480A0 (en) Improved condom
AU2009901921A0 (en) Treatment & Immunotherapy
AU2009906191A0 (en) Preparation of charged membranes
AU2009904601A0 (en) Method four
AU2009900438A0 (en) Method four
AU2009905173A0 (en) Methods of treatment
AU2009904460A0 (en) Methods of treatment
AU2009902633A0 (en) Methods of treatment
AU2009903930A0 (en) Novel compounds and their uses
AU2009903242A0 (en) MD Drillbolt
AU2009903360A0 (en) Method of Treatment

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10739112

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10739112

Country of ref document: EP

Kind code of ref document: A2